104 related articles for article (PubMed ID: 23376077)
1. Risedronate increases osteoblastic differentiation and function through connexin43.
Jeong HM; Jin YH; Choi YH; Chung JO; Cho DH; Chung MY; Civitelli R; Chung DJ; Lee KY
Biochem Biophys Res Commun; 2013 Mar; 432(1):152-6. PubMed ID: 23376077
[TBL] [Abstract][Full Text] [Related]
2. Risedronate positively affects osteogenic differentiation of human mesenchymal stromal cells.
Casado-Díaz A; Santiago-Mora R; Dorado G; Quesada-Gómez JM
Arch Med Res; 2013 Jul; 44(5):325-34. PubMed ID: 23867791
[TBL] [Abstract][Full Text] [Related]
3. COMP-Ang1, a chimeric form of Angiopoietin 1, enhances BMP2-induced osteoblast differentiation and bone formation.
Jeong BC; Kim HJ; Bae IH; Lee KN; Lee KY; Oh WM; Kim SH; Kang IC; Lee SE; Koh GY; Kim KK; Koh JT
Bone; 2010 Feb; 46(2):479-86. PubMed ID: 19782780
[TBL] [Abstract][Full Text] [Related]
4. Effect of risedronate on osteoblast differentiation, expression of receptor activator of NF-κB ligand and apoptosis in mesenchymal stem cells.
Fujita H; Kurokawa K; Ogino T; Ono M; Yamamoto M; Oka T; Nakanishi T; Kobayashi N; Tanaka N; Ogawa T; Suzaki E; Utsumi K; Sasaki J
Basic Clin Pharmacol Toxicol; 2011 Aug; 109(2):78-84. PubMed ID: 21332944
[TBL] [Abstract][Full Text] [Related]
5. Harmine promotes osteoblast differentiation through bone morphogenetic protein signaling.
Yonezawa T; Lee JW; Hibino A; Asai M; Hojo H; Cha BY; Teruya T; Nagai K; Chung UI; Yagasaki K; Woo JT
Biochem Biophys Res Commun; 2011 Jun; 409(2):260-5. PubMed ID: 21570953
[TBL] [Abstract][Full Text] [Related]
6. Osteoblast proliferation and maturation by bisphosphonates.
Im GI; Qureshi SA; Kenney J; Rubash HE; Shanbhag AS
Biomaterials; 2004 Aug; 25(18):4105-15. PubMed ID: 15046901
[TBL] [Abstract][Full Text] [Related]
7. Berberine bioisostere Q8 compound stimulates osteoblast differentiation and function in vitro.
Han Y; Jin Y; Lee SH; Khadka DB; Cho WJ; Lee KY
Pharmacol Res; 2017 May; 119():463-475. PubMed ID: 28286134
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of osteoblastic differentiation by warfarin and 18-α-glycyrrhetinic acid.
Jeong HM; Cho DH; Jin YH; Chung JO; Chung MY; Chung DJ; Lee KY
Arch Pharm Res; 2011 Aug; 34(8):1381-7. PubMed ID: 21910061
[TBL] [Abstract][Full Text] [Related]
9. Reduction of protein phosphatase 2A Cα enhances bone formation and osteoblast differentiation through the expression of bone-specific transcription factor Osterix.
Okamura H; Yoshida K; Ochiai K; Haneji T
Bone; 2011 Sep; 49(3):368-75. PubMed ID: 21683816
[TBL] [Abstract][Full Text] [Related]
10. Ugonin K promotes osteoblastic differentiation and mineralization by activation of p38 MAPK- and ERK-mediated expression of Runx2 and osterix.
Lee CH; Huang YL; Liao JF; Chiou WF
Eur J Pharmacol; 2011 Oct; 668(3):383-9. PubMed ID: 21806985
[TBL] [Abstract][Full Text] [Related]
11. ODDD-linked Cx43 mutants reduce endogenous Cx43 expression and function in osteoblasts and inhibit late stage differentiation.
McLachlan E; Plante I; Shao Q; Tong D; Kidder GM; Bernier SM; Laird DW
J Bone Miner Res; 2008 Jun; 23(6):928-38. PubMed ID: 18269311
[TBL] [Abstract][Full Text] [Related]
12. Osterix plays a critical role in BMP4-induced promoter activity of connexin43.
Han Y; Cho DH; Chung DJ; Lee KY
Biochem Biophys Res Commun; 2016 Sep; 478(2):683-8. PubMed ID: 27498006
[TBL] [Abstract][Full Text] [Related]
13. Is 1, 25-dihydroxyvitamin D3 an ideal substitute for dexamethasone for inducing osteogenic differentiation of human adipose tissue-derived stromal cells in vitro?
Zhou YS; Liu YS; Tan JG
Chin Med J (Engl); 2006 Aug; 119(15):1278-86. PubMed ID: 16919187
[TBL] [Abstract][Full Text] [Related]
14. Effects of bisphosphonates on proliferation and osteoblast differentiation of human bone marrow stromal cells.
von Knoch F; Jaquiery C; Kowalsky M; Schaeren S; Alabre C; Martin I; Rubash HE; Shanbhag AS
Biomaterials; 2005 Dec; 26(34):6941-9. PubMed ID: 16009417
[TBL] [Abstract][Full Text] [Related]
15. Ethanol extract of Lithospermum erythrorhizon Sieb. et Zucc. promotes osteoblastogenesis through the regulation of Runx2 and Osterix.
Choi YH; Kim GS; Choi JH; Jin SW; Kim HG; Han Y; Lee DY; Choi SI; Kim SY; Ahn YS; Lee KY; Jeong HG
Int J Mol Med; 2016 Aug; 38(2):610-8. PubMed ID: 27353217
[TBL] [Abstract][Full Text] [Related]
16. Epinephrine accelerates osteoblastic differentiation by enhancing bone morphogenetic protein signaling through a cAMP/protein kinase A signaling pathway.
Uemura T; Ohta Y; Nakao Y; Manaka T; Nakamura H; Takaoka K
Bone; 2010 Oct; 47(4):756-65. PubMed ID: 20637325
[TBL] [Abstract][Full Text] [Related]
17. Osteoclast inhibitory lectin (OCIL) inhibits osteoblast differentiation and function in vitro.
Nakamura A; Ly C; Cipetić M; Sims NA; Vieusseux J; Kartsogiannis V; Bouralexis S; Saleh H; Zhou H; Price JT; Martin TJ; Ng KW; Gillespie MT; Quinn JM
Bone; 2007 Feb; 40(2):305-15. PubMed ID: 17049328
[TBL] [Abstract][Full Text] [Related]
18. Communication-dependent mineralization of osteoblasts via gap junctions.
Hashida Y; Nakahama K; Shimizu K; Akiyama M; Harada K; Morita I
Bone; 2014 Apr; 61():19-26. PubMed ID: 24389413
[TBL] [Abstract][Full Text] [Related]
19. Metformin induces osteoblast differentiation via orphan nuclear receptor SHP-mediated transactivation of Runx2.
Jang WG; Kim EJ; Bae IH; Lee KN; Kim YD; Kim DK; Kim SH; Lee CH; Franceschi RT; Choi HS; Koh JT
Bone; 2011 Apr; 48(4):885-93. PubMed ID: 21147283
[TBL] [Abstract][Full Text] [Related]
20. Connexin43 and Runx2 Interact to Affect Cortical Bone Geometry, Skeletal Development, and Osteoblast and Osteoclast Function.
Buo AM; Tomlinson RE; Eidelman ER; Chason M; Stains JP
J Bone Miner Res; 2017 Aug; 32(8):1727-1738. PubMed ID: 28419546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
